The Inhaled Antibiotics Market size is expected to grow at an annual average of 6% during 2022-2028. The management of patients with chronic respiratory diseases have become a challenge in clinical practice. Conditions such as cystic fibrosis (CF) and non-CF bronchiectasis require extensive treatment strategies to deal with multidrug resistant pathogens that include Pseudomonas aeruginosa, […]
